Literature DB >> 32046143

Modeling Spontaneous Bone Metastasis Formation of Solid Human Tumor Xenografts in Mice.

Vera Labitzky1, Anke Baranowsky2, Hanna Maar1, Sandra Hanika1, Sarah Starzonek1, Ann-Kristin Ahlers1, Katrin Stübke1, Eva J Koziolek1,3, Markus Heine1,4, Paula Schäfer5, Sabine Windhorst5, Manfred Jücker5, Kristoffer Riecken6, Michael Amling2, Thorsten Schinke2, Udo Schumacher1, Ursula Valentiner1, Tobias Lange1.   

Abstract

The majority of cancer-related deaths are due to hematogenous metastases, and the bone marrow (BM) represents one of the most frequent metastatic sites. To study BM metastasis formation in vivo, the most efficient approach is based on intracardiac injection of human tumor cells into immunodeficient mice. However, such a procedure circumvents the early steps of the metastatic cascade. Here we describe the development of xenograft mouse models (balb/c rag2-/- and severe combined immunodeficient (SCID)), in which BM metastases are spontaneously derived from subcutaneous (s.c.) primary tumors (PTs). As verified by histology, the described methodology including ex vivo bioluminescence imaging (BLI) even enabled the detection of micrometastases in the BM. Furthermore, we established sublines from xenograft primary tumors (PTs) and corresponding BM (BM) metastases using LAN-1 neuroblastoma xenografts as a first example. In vitro "metastasis" assays (viability, proliferation, transmigration, invasion, colony formation) partially indicated pro-metastatic features of the LAN-1-BM compared to the LAN-1-PT subline. Unexpectedly, after s.c. re-injection into mice, LAN-1-BM xenografts developed spontaneous BM metastases less frequently than LAN-1-PT xenografts. This study provides a novel methodologic approach for modelling the spontaneous metastatic cascade of human BM metastasis formation in mice. Moreover, our data indicate that putative bone-metastatic features get rapidly lost upon routine cell culture.

Entities:  

Keywords:  bioluminescence imaging; spontaneous bone marrow metastasis; xenograft mouse model

Year:  2020        PMID: 32046143     DOI: 10.3390/cancers12020385

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  5 in total

Review 1.  Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors.

Authors:  Li Liu; Devin O'Kelly; Regan Schuetze; Graham Carlson; Heling Zhou; Mary Lynn Trawick; Kevin G Pinney; Ralph P Mason
Journal:  Molecules       Date:  2021-04-27       Impact factor: 4.411

2.  Insights into the Steps of Breast Cancer-Brain Metastases Development: Tumor Cell Interactions with the Blood-Brain Barrier.

Authors:  Fabienne Hamester; Christine Stürken; Ceren Saygi; Minyue Qi; Karen Legler; Christian Gorzelanny; José R Robador; Barbara Schmalfeldt; Elena Laakmann; Volkmar Müller; Isabell Witzel; Leticia Oliveira-Ferrer
Journal:  Int J Mol Sci       Date:  2022-02-08       Impact factor: 5.923

3.  Immune characterization of pre-clinical murine models of neuroblastoma.

Authors:  Emily R Webb; Silvia Lanati; Carol Wareham; Alistair Easton; Stuart N Dunn; Tatyana Inzhelevskaya; Freja M Sadler; Sonya James; Margaret Ashton-Key; Mark S Cragg; Stephen A Beers; Juliet C Gray
Journal:  Sci Rep       Date:  2020-10-07       Impact factor: 4.379

4.  CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivo.

Authors:  Su Jung Oh-Hohenhorst; Derya Tilki; Ann-Kristin Ahlers; Anna Suling; Oliver Hahn; Pierre Tennstedt; Christiane Matuszcak; Hanna Maar; Vera Labitzky; Sandra Hanika; Sarah Starzonek; Simon Baumgart; Steven A Johnsen; Martina Kluth; Hüseyin Sirma; Ronald Simon; Guido Sauter; Hartwig Huland; Udo Schumacher; Tobias Lange
Journal:  Cancer Gene Ther       Date:  2021-01-07       Impact factor: 5.987

5.  GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.

Authors:  Anna Mukha; Uğur Kahya; Annett Linge; Oleg Chen; Steffen Löck; Vasyl Lukiyanchuk; Susan Richter; Tiago C Alves; Mirko Peitzsch; Vladyslav Telychko; Sergej Skvortsov; Giulia Negro; Bertram Aschenbrenner; Ira-Ida Skvortsova; Peter Mirtschink; Fabian Lohaus; Tobias Hölscher; Hans Neubauer; Mahdi Rivandi; Vera Labitzky; Tobias Lange; André Franken; Bianca Behrens; Nikolas H Stoecklein; Marieta Toma; Ulrich Sommer; Sebastian Zschaeck; Maximilian Rehm; Graeme Eisenhofer; Christian Schwager; Amir Abdollahi; Christer Groeben; Leoni A Kunz-Schughart; Gustavo B Baretton; Michael Baumann; Mechthild Krause; Claudia Peitzsch; Anna Dubrovska
Journal:  Theranostics       Date:  2021-06-26       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.